Physician profile
Danny S Park
NPI 1811148786
$18,962.56
in general payments reported to CMS, 2019-2025
47 companies · $61.21 in 2025
The $61.21 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $1,691 · 2021: $1,197 · 2022: $806 · 2023: $3,836 · 2024: $601 · 2025: $61.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,630 · Food and Beverage: $1,868.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,629.75 |
| Food and Beverage | $1,867.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acorda Therapeutics, INC | $10,191.62 | 2019-2024 | Inbrija, Ampyra |
| Siemens Medical Solutions USA, INC. | $3,076.98 | 2023 | |
| Biogen, INC. | $646.47 | 2019-2025 | Vumerity, Tysabri, Plegridy |
| Abbvie INC. | $547.81 | 2019-2025 | |
| Ucb, INC. | $539.81 | 2019-2024 | Briviact, Rystiggo |
| Alexion Pharmaceuticals, INC. | $435.85 | 2019-2024 | Ultomiris, Soliris |
| Teva Pharmaceuticals USA, INC. | $307.46 | 2019-2025 | Austedo, Ajovy |
| Lilly USA, LLC | $273.87 | 2019-2024 | Emgality, Reyvow |
| Allergan, INC. | $224.16 | 2019-2021 | |
| Emd Serono, INC. | $220.52 | 2019-2023 | Mavenclad |
| Mdd US Operations, LLC | $191.38 | 2019-2024 | Gocovri, Gocovri |
| Lundbeck LLC | $184.30 | 2019-2024 | Vyepti |
| Sunovion Pharmaceuticals INC. | $164.99 | 2019-2022 | |
| Acadia Pharmaceuticals INC | $164.72 | 2019-2024 | Nuplazid |
| Amgen INC. | $148.88 | 2020-2022 |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danny Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.